我们从SMA的新疗法中学到了什么? 一个叙事审查
Eugenio Mercuri1,2, Gianpaolo Cicala1,2, Marianna Villa2
1Department of Neuroscience, Catholic University of The Sacred Heart, Rome, Italy.
概括
脊椎肌肉缩 (SMA) 的早期治疗可以最大限度地提高运动结果,即使是在后期阶段. 新数据揭示了扩大治疗窗口和影响SMA患者治疗疗效的关键因素.
科学领域:
- 神经学 神经学
- 遗传学 是一个遗传学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 脊髓肌肉缩 (SMA) 是一种遗传性神经肌肉疾病,其特征是运动神经元退化.
- 疾病修饰疗法已经将SMA管理从息性转变为主动性.
- 对SMA表型和治疗反应的不断变化的理解需要对疾病自然史进行重新评估.
研究的目的:
- 分析SMA近期治疗进展的经验教训.
- 关注关键方面:治疗窗口,早期治疗影响,疾病进展和治疗疗效的修饰因素.
- 提供对新型数据分析模型的见解,以优化患者护理和个性化治疗策略.
主要方法:
- 对SMA治疗的临床试验和现实世界数据的审查.
- 分析患者数据以确定治疗反应的决定因素.
- 使用长期患者数据进行预测建模的探索.
主要成果:
- 早期治疗,特别是临床前治疗,可以显著地最大限度地提高SMA的运动结果.
- 有证据表明,治疗窗口可以扩展到生命的前几个月之外.
- 基线功能,SMN2拷贝数和治疗时的年龄是反应的关键决定因素.
结论:
- 早期干预对于SMA的最佳运动结果至关重要.
- 对于SMA治疗的治疗窗口比以前理解的更广泛.
- 基于预测模型的个性化治疗策略对于优化SMA患者轨迹至关重要.
更多相关视频
05:55Delivery of Therapeutic Agents Through Intracerebroventricular ICV and Intravenous IV Injection in Mice
Published on: October 3, 2011
59.5K
06:51Systemic Delivery of MicroRNA Using Recombinant Adeno-associated Virus Serotype 9 to Treat Neuromuscular Diseases in Rodents
Published on: August 10, 2018
7.6K
相关概念视频
Myasthenia Gravis: Overview and Treatment
1.0K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.0K
Satellite Stem Cells and Muscular Dystrophy
1.9K
Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
1.9K
Skeletal Muscle Relaxants: Therapeutic Uses
444
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
444
